Close Menu

NEW YORK – A research study has shown that genetic testing to help guide medication decisions after a heart procedure is non-inferior to standard treatment.

Led by senior author Jurriën ten Berg of St. Antonius Hospital in Nieuwegein, the Netherlands, researchers conducting the POPular Genetics study compared a genotype-guided strategy of selecting anti-platelet medication to accompany primary percutaneous coronary intervention (PCI) with standard treatment of one of two platelet inhibitors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.